Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.50p -3.09% 47.00p 46.00p 48.00p 48.50p 47.00p 48.50p 95,350 09:20:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 0.0 -16.5 -17.6 - 91.45

Advanced Oncotherapy Share Discussion Threads

Showing 5026 to 5048 of 5400 messages
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older
DateSubjectAuthorDiscuss
14/3/2018
09:58
both of which are different to Hardman - poor show for AVO to have inconsistent statements over matters to which significance is attached.
twirl
13/3/2018
18:25
According to AVO "The site is expected to be ready for installation by H1 2019" and "the first patient treatment at Harley Street is expected in H2 2020." I assume that H1 2019 means the first half of 2019 and H2 2020 means the second half of 2020.
daijavu
12/3/2018
10:00
AVO says; "Beam through first CCLs expected by mid 2018"
daijavu
11/3/2018
16:56
When's news due? End of March?
paul_98
01/3/2018
13:21
Looking smart. hxxp://www.advancedoncotherapy.com/Portals/0/Documents/Investors/AVO%20LIGHT%20System%20Brochure.pdf
paul_98
23/2/2018
09:31
You could try website, upload photos and share the link: hxxps://imgbb.com/
marvin66
22/2/2018
13:03
Just shows the large hole with a digger down the bottom and loads of supports keeping the neighbouring properties from falling in!
waterloo01
22/2/2018
13:01
Mmm, not sure then I'm afraid
scottishfield
22/2/2018
12:58
nothing happens when I copy and try and paste into here?
waterloo01
22/2/2018
12:42
I thin if you right click on a picture, you can take it from there via the options waterlooO1; copy & paste etc
scottishfield
17/2/2018
23:11
I hope the same. If it is all true and on target (as promised), then we are in for excellent money.
paul_98
16/2/2018
11:58
Against my better judgement, I've just topped up. however, I am mindful that AVO was at precisely this place two years ago. According to the BoD, the development of LIGHT was on target to be completed before the end of 2016, they had been awarded contracts in China, signed in front of our PM, David Cameron and senior members of the Chinese Government, and had just raised a substantial amount of cash to bring everything to a conclusion. You would never imagine any of that had happened. It has been erased from the record. I only hope it is different this time.
daijavu
16/2/2018
10:23
...........the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the GBP13,500,000 payable by Yantai Cipu for the subscription for 45,000,000 new ordinary shares of GBP0.25 each to be issued by the Company to Yantai Cipu (the "Subscription") at GBP0.30 per share (the "Subscription Price").
jayj4u
16/2/2018
09:28
Selling? What? This is an incredible share price, in my humble opinion 100p plus very soon.
paul_98
16/2/2018
09:03
I studied Physics at UCL and my favorite subject was atomic physics. I can tell you that the technology they are developing has massive implication. My professors were working at CERN and i think this company has hit the JACKPOT! I will be visiting my university next week and speaking to professors regarding this company and its technology.
jayj4u
16/2/2018
08:37
It will. This will,IMO, not all be happening without massive inside knowledge of the progress. SO POSITIVE!!! Yes!
paul_98
16/2/2018
08:24
It is good news but I still remain cautious. A lot depends on the technology being fully developed to the timeline promised by the BoD so that production can go ahead.
daijavu
16/2/2018
07:34
THIS IS THE MOST IMPORTANT PART!!!! Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company.
jayj4u
16/2/2018
07:16
RNS Number : 0737F Advanced Oncotherapy PLC 16 February 2018 ADVANCED ONCOTHERAPY PLC ("Advanced Oncotherapy" or the "Company") Completion of the Subscription Agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that in relation to the announcement dated 7 December 2017 and following the passing of the resolution proposed for the vote of the Company' shareholders on 23 January 2018, the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the GBP13,500,000 payable by Yantai Cipu for the subscription for 45,000,000 new ordinary shares of GBP0.25 each to be issued by the Company to Yantai Cipu (the "Subscription") at GBP0.30 per share (the "Subscription Price"). As a consequence of the completion of the Subscription by Yantai Cipu, and as detailed in the circular dated 22 December 2017 (the "Circular"), the placing of 10,868,782 new ordinary shares with new and existing investors at the Subscription Price (the "Placing"), as well as the conversion of the loan made by Swedish Investors by way of issue of 13,697,697 new ordinary shares (the "Conversion"), have also been completed. Application has been made for admission to trading on AIM ("Admission") of the 69,566,479 new ordinary shares deriving from the Subscription, the Placing and the Conversion and it is expected that Admission will occur on or around 22 February 2018. Following Admission, the total number of ordinary shares in issue will be 150,501,673 and Yantai Cipu will hold 29.90% of the enlarged issued share capital of the Company. Yantai Cipu has also informed the Company that they are in advanced negotiation with a major medical equipment and pharmaceutical distribution company in China for a collaboration to accelerate and strengthen their market access in the People's Republic of China, Hong Kong, Macau, Taiwan and South Korea (the "Territories"). The Company and Yantai Cipu have agreed that it is in the best interest of the Company and its shareholders to extend the Long Stop Date for the Distribution Agreement until 31 March 2018 to enable the satisfactory completion of the negotiations with the new participant. The commitment of Yantai Cipu vis-à-vis the Distribution Agreement is unchanged, and the receipt of the GBP16,500,000 payment from Yantai Cipu relating to the commercial agreement with Yantai Cipu also announced on 7 December 2017 is not conditional on the completion of negotiations with the distribution company. The receipt of funds in relation to the commercial agreement is subject to approval from the Government of the People's Republic of China for the transfer of monies to the United Kingdom. Lancea LLP advised the Company on the Subscription and Distribution agreements made by Yantai Cipu. For further information, please contact:
jayj4u
14/2/2018
09:14
Very quiet chat forum! Any thoughts out there on this?
paul_98
09/2/2018
16:50
Solid end to this week. Considering world markets we can feel good here. GLA.
paul_98
09/2/2018
09:27
Good point. I would have hoped for some sort of update on this progress.
paul_98
09/2/2018
08:31
Hi Paul I would hope monies will be received soon especially with Chinese New Year upon us the end of next week which will basically be then a 2 week shut down. I would be very surprised if it is not before this time.
makeamillion1
Chat Pages: Latest  204  203  202  201  200  199  198  197  196  195  194  193  Older
Your Recent History
LSE
AVO
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190521 11:27:36